OPDIVO QVANTIG (nivolumab and hyaluronidase-nvhy)

**Product type:** Human Prescription Drug

**Active ingredient:** HYALURONIDASE (HUMAN RECOMBINANT); NIVOLUMAB

**Strength:** 2000; 120 U/mL; mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** E.R. Squibb & Sons, L.L.C.

**Marketing category:** BLA (BLA761381)

**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]